Claudin-1 as a target for modulation of epidermal barriers
Project/Area Number |
24390042
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Medical pharmacy
|
Research Institution | Osaka University |
Principal Investigator |
KONDOH Masuo 大阪大学, 薬学研究科(研究院), 准教授 (50309697)
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥18,590,000 (Direct Cost: ¥14,300,000、Indirect Cost: ¥4,290,000)
Fiscal Year 2014: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2013: ¥6,630,000 (Direct Cost: ¥5,100,000、Indirect Cost: ¥1,530,000)
Fiscal Year 2012: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
|
Keywords | タイトジャンクション / 非侵襲性投与 / Claudin / Tight junction / 上皮バリア / tight junction / claudin |
Outline of Final Research Achievements |
Epithelium plays pivotal roles in barriers that separate the inside of the body from the outside environment. Passage across epithelial barriers is the first step in drug absorption. Epidermal absorption is an ideal route for drug administration because it is non-invasive and easily controlled. Claudin-1 (CLDN1) seals tight junctions in the stratum granulosum, but whether modulation of CLDN1 enhances epidermal permeability is unclear. We developed anti-CLDN1 antibody, and we investigated the effect of an anti-CLDN1 antibody on the epidermal epithelial barrier by using human epidermal keratinocytes (NHEK), a popular in vitro model of human epithelial cell sheets. Treatment of NHEK monolayers with anti-CLDN1 antibody decreased the integrity of tight junctions between adjacent cells and enhanced the permeation of solutes across the cell sheets. These findings suggest that CLND1 may be a target for specific modulation of epidermal barrier.
|
Report
(4 results)
Research Products
(89 results)
-
-
-
[Journal Article] Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model2015
Author(s)
Masayoshi Fukasawa, Shotaro Nagase, Yoshitaka Shirasago, Manami Iida, Mayo Yamashita, Kohki Endo, Kiyohito Yagi, Tetsuro Suzuki, Takaji Wakita, Kentaro Hanada, Hiroki Kuniyasu, Masuo Kondoh
-
Journal Title
J Virol.
Volume: 89
Pages: 4866-4879
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
[Journal Article] Development of an anti-claudin-3 and -4 bispecific monoclonal antibody for cancer diagnosis and therapy2014
Author(s)
Xiangru Li, Manami Iida, Minoru Tada, Akihiro Watari, Yumi Kawahigashi, Yuka Kimura, Taku Yamashita, Akiko Ishii-Watabe, Tadayuki Uno, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi, Masuo Kondoh
-
Journal Title
Journal of Pharmacology and Experimental Therapeutics
Volume: 351
Pages: 206-213
DOI
Related Report
Peer Reviewed / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Creatioll and biochemical analysis of a broad-specific claudin binder2012
Author(s)
Azusa Takahashi, Yumiko Saito, Masuo Kondoh, Kyohei Matsushi ta, Susanne M. Krug, Hidehiko Suzuki, Hirofumi Tsujino, Xiangru Li, Hiroshi Aoyama, Koji Matsuhisa, Tadayuki Uno, Michael Fromm, Takao Hamakubo, Kiyohito Yagi
-
Journal Title
Biomatcrials
Volume: 33
Pages: 3464-3474
Related Report
Peer Reviewed
-
-
-
-
[Presentation] Anti-human claudin-1 monoclonal antbodies as anti-Hepatitis C Virus agents2014
Author(s)
M. Iida, M. Yamashita, S. Nagase, M. Tada, Y. Shirasago, M. Fukasawa, A.Watari, A.Ishii-Watabe, K. Yagi, M. Kondoh
Organizer
Antibody Engineering & Therapeutics 2014
Place of Presentation
Huntington Beach, CA, U.S.A.
Year and Date
2014-12-07 – 2014-12-11
Related Report
Invited
-
-
[Presentation] Development of a Novel Bispecific Anti-Claudin Antibody and its Anti-Tumor Activity2014
Author(s)
Y. Kimura, X. Li, M. Iida, M. Tada, A. Watabe-Ishii, M. Fukasawa, Y. Kawahigashi, A. Watari, K. Yagi, M. Kondoh
Organizer
Antibody Engineering & Therapeutics 2014
Place of Presentation
Huntington Beach, CA, U.S.A.
Year and Date
2014-12-07 – 2014-12-11
Related Report
Invited
-
-
[Presentation] In vivo inhibition of hepatitis C virus infection by anti-claudin-1 monoclonal antibodies2014
Author(s)
M.Iida, S.Nagase, M.Yamashita, Y.Shirasago, M.Fukasawa, M.Tada, A.Ishii, A.Watari, K.Yagi, and M.Kondoh
Organizer
The 41st Annual Meeting & Exposition of the controlled Release Society
Place of Presentation
Chicago, U.S.A.
Year and Date
2014-07-13 – 2014-07-16
Related Report
Invited
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Characterization of scFv libraries derived from mice differently immunized with claudin.2013
Author(s)
Yamashita, M.; Nagase, S.; Takahashi, A.; Iwanari, H.; Kondoh, M.; Watari, A.; Hamakubo, T.; Yagi, K
Organizer
Experimental Biology 2013
Place of Presentation
Boston, MA, USA
Related Report
-
-
-
-
-
-
-
-
-
[Presentation] Inhibition of hepatitis C virus infection by mouse anti-claudin 1 monoclonal antibodies2013
Author(s)
Fukasawa, M.; Nagase, S.; Yamashita, M.; Iida, M.; Shirasago, Y.; Watari, A.; Suzuki, T.; Wakita, T.; Yagi, K.; Kondoh, M
Organizer
HCV2013 20th International Symposium on Hepatittis C virus and Relate viruses 2013
Place of Presentation
Melbourne, Australia.
Related Report
-
-
[Presentation] Creation of a broadly specific claudin binder and its absorption-enhancing activity2013
Author(s)
Doyama, R.; Matsushita, K.; Takahashi, A.; Matsuhisa, K.; Watari, A.; Hamakubo, T.; Yagi, K.; Kondoh, M
Organizer
2013 AAPS Annual Meeting and Exposition
Place of Presentation
San Antonio, TX, USA
Related Report
-
[Presentation] Development of claudin-4-specific monoclonal antibodies and their anti-tumor activities2013
Author(s)
Iida, M.; Li, X.; Kuniyasu, H.; Fukasawa, M.; Tada, M.; Ishii, A.; Watari, A.; Yagi, K.; Kondoh, M.
Organizer
Antibody Engineering & Terapeutics 2013
Place of Presentation
Huntington Beach, CA, USA
Related Report
-
[Presentation] Claudin-1-specific monoclonal antibodies and their inhibitory activity against hepatitis C virus infection2013
Author(s)
Nagase, S.; Yamashita, M.; Iida, M.; Shirasago, Y.; Fukasawa, M.; Watari, A.; Yagi, K.; Kondoh, M.
Organizer
Antibody Engineering & Terapeutics 2013
Place of Presentation
Huntington Beach, CA, USA
Related Report
-
-
[Presentation] In vitro and in vivo inhibition of hepatitis C virus infection by mouse anti-human claudin 1 monoclonal antibodies2013
Author(s)
Fukasawa, M.; Nagase, S.; Yamashita, M.; Iida, M.; Shirasago, Y.; Hanada, K.; Watari, A.; Yagi, K.; Kondoh, M
Organizer
53rd Annual meeting of the American society for cell biology
Place of Presentation
New Orleans, LO, USA
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Preparation of a broad-specific claudin binder by using Clotridium perfringcns enterotoxin.2012
Author(s)
Hidehiko Suzuki, Azusa Takahashi, Koji Mat sushita, Xiangru Li, Hiroshi Tsujino, Akihiro Watari, Masuo Kondoh, Hiroshi Aoyama, Tadayuki Uno, Kiyohito Yagi
Organizer
Experimental Biology 2012
Place of Presentation
San Diego, USA
Related Report
-
-
-
[Presentation] Biochemical analysis of a claudin ligand that exhibits a broad binding specificity2012
Author(s)
Ryo Doyama, Hidehiko Suzuki, Kyohei Matsushita、Xiangru Li, Azusa Takahashi, Koji Matsuhisa, Hiorshi Tsujino, Akihiro Watari、Masuo Kondoh, Hiroshi Aoyama, Tadayuki Uno, Kiyohito Yagi
Organizer
Tight junction conference 2012
Place of Presentation
Merida, MEXICO
Related Report
-
[Presentation] Structual and biochemical analysis of a novel, broadly specific claudin binder2012
Author(s)
Shotaio Nagase, Koj i Matsushita, Azusa Takahashi, Hiroshi Tsujino, Xiangru Li, Hidehiko Suzuki, Hiroshi. Aoyama, Masuo Kondoh, Akihiro Watari, Tadayuki Uno, Takao Hamakubo, Kiyohito Yagi
Organizer
52nd Annual meeting of the American society for Ce11 Biology
Place of Presentation
San Francisco, USA
Related Report
-
-
-
-
-
-